Skip to main content

A Multifaceted Intervention Strategy for Eradication of a Hospital-Wide Outbreak Caused by Carbapenem-Resistant Klebsiella pneumoniae in Southern Israel

  • Abraham Borer (a1), Seada Eskira (a1), Ronit Nativ (a1), Lisa Saidel-Odes (a2), Klaris Riesenberg (a2), Ilana Livshiz-Riven (a1), Francisc Schlaeffer (a2), Michael Sherf (a3) and Nejama Peled (a4)...

To devise a local strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae (CRKP).


Quasi-experimental, before-and-after, interrupted time-series study.


A 1,000-bed tertiary-care university teaching hospital.


Retrospectively, all relevant data were collected from the medical records of patients with CRKP infections from May 2006 through April 2007, the preintervention period. From May 1, 2007, through May 1, 2010, the postintervention period, the intervention was applied and prospectively followed. The 5 key elements of this strategy were an emergency department flagging system, the building of a cohort ward, the eradication of clusters, environmental and personnel hand cultures, and a carbapenem-restriction policy. The demographic and clinical parameters of patients colonized by and/or infected with CRKP were collected from medical records.


A total of 10,680 rectal cultures were performed for 8,376 patients; 433 (5.16%) and 370 (4.4%) were CRKP-colonized and CRKP-infected patients, respectively, and 789 (98%) of 803 patients were admitted to the CRKP cohort ward. The CRKP infection density was reduced from 5.26 to 0.18 per 10,000 patient-days (P<.001), and no nosocomial CRKP infections were diagnosed. Twenty-three percent of environmental cultures were found to be positive. Meropenem use was reduced from 283 ± 70.92 to 118 ± 74.32 defined daily doses per 1,000 patient-days (P<.001).


This intervention produced an enormous impact on patient location, surveillance cultures, and antibiotic policies and a massive investment in infection control resources.

Corresponding author
Infection Control and Hospital Epidemiology Unit, Soroka University Medical Center, PO Box 151, Beer-Sheva 84101, Israel (
Hide All
1. Nordmann, P, Cuzon, G, Nass, T. The real treat of Klebsiella pneumoniae carbapenase-producing bacteria. Lancet Infect Dis 2009;9:228236.
2. Souli, M, Galani, I, Antoniadou, A, et al. An outbreak of infection due to β-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010;50:364373.
3. Borer, A, Saidel-Odes, L, Riesenberg, K, et al. Attributable mortality rate of carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009;30:972976.
4. Centers for Disease Control and Prevention. Guidelines for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care settings. MMWR Morb Mortal Wkly Rep 2009;58:256260.
5. World Health Organization Collaborating Center for Drug Statistics Methodology. ATC/DDD index 2011. Last updated August 11, 2008.
6. Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 16th informational supplement. CLSI document M100-S16. Wayne, PA: CLSI, 2006.
7. Anderson, KF, Lonsway, DR, Rasheed, JK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenase in Enterobacteriaceae. J Clin Microbiol 2007;45:27232725.
8. Wagner, AK, Soumerai, SB, Zhang, F, Ross-Degnan, D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299309.
9. Navon-Venezia, S, Leavitt, A, Schwaber, M, et al; Israeli HPC Kpn Study Group. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 2009;53:818820.
10. Harris, AD, McGregor, JC, Furuno, JP. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis 2006;43:S57S61.
11. Saidel-Odes, L, Polachek, H, Peled, N, et al. Randomized, double-blind, placebo-controlled phase 4 trial of selective digestive decontamination (SDD) with oral gentamicin and polymyxin E for eradication of carbapenem-resistant Klebsiella pneumonia (CRKP) carriage. Abstract presented at: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 12-15, 2010; Boston.
12. Talon, D, Vichard, P, Muller, A, Bertin, M, Jeunet, L, Bertrand, X. Modelling the usefulness of a dedicated cohort facility to prevent the dissemination of MRSA. J Hosp Infect 2003;54:5762.
13. Ben-Daviv, D, Maor, Y, Keller, N, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010;31:620626.
14. Lemmen, SW, Hafner, H, Zolldann, D, Stanzel, S, Lutticken, R. Distribution of multi-resistant gram-negative versus gram-positive bacteria in the hospital inanimate environment. J Hosp Infect 2004;56:191197.
15. Hussein, K, Sprecher, J, Mashiach, T, Oren, I, Kassis, I, Finkelstein, R. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009;30:666671.
16. Schwaber, MJ, Klarfeld, L, Navon-Venezia, S, Schwartz, D, Leavitt, A, Carmeli, Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52: 1028-1033.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed